Format

Send to

Choose Destination
Hum Vaccin. 2009 Dec;5(12):832-8. Epub 2009 Dec 11.

Vaccines against tularemia.

Author information

1
University of Maryland School of Medicine, Center for Vaccine Development, Baltimore, MD, USA. ebarry@medicine.umaryland.edu

Abstract

Francisella tularensis is a Category A select agent for which vaccine and countermeasure development are a priority. In the past eight years, renewed interest in this pathogen has led to the generation of an enormous amount of new data on both the pathogen itself and its interaction with host cells. This information has fostered the development of various vaccine candidates including acellular subunit, killed whole cell and live attenuated. This review summarizes the progress and promise of these various candidates.

PMID:
19923904
PMCID:
PMC3132883
DOI:
10.4161/hv.10297
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center